UGT2A3P7

Across TCGA pan-cancer cohorts, UGT2A3P7 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of UGT2A3P7’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where UGT2A3P7 RNA is repressed in tumor relative to normal tissue. In most cancer types UGT2A3P7 is over-expressed in tumor, although a few such as KIRC and CHOL show the opposite, repressed pattern.

KIRC, CHOL, and LIHC are the cancer types where UGT2A3P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UGT2A3P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.041	<.001	6	view →
CHOL	All	All	−0.408	.004	2	view →
LIHC	Male	All	+0.226	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

UGT2A3P7–KIRC

Open the KIRC breakdown →